CONTENTS
3 Biosimilar terminology and definitions : A glossary James Stevenson
7 Biosimilar regulatory framework and considerations James Stevenson
11 Biosimilars in the US : Current and future landscape Ashley Glode and Megan May
15 Cost-savings through use of oncology biosimilars in the US Shannon Ugarte and Kevin Knopf
18 Challenges and impact of biosimilars in value-based cancer care Sandra Cuellar
22 Factors determining inclusion of biosimilars onto formularies Ali McBride
25 Biosimilars : The promise to mitigate health care costs Jorge Garcia
28 The role of the pharmacist as the local biosimilar expert Ali McBride
31 Oncology biosimilars : Patient access and administration Welly Menty , Ashim Malhotra , Erica Young , Nivaz Brar , Bin Guan and Xiaodong Feng
Content Director , Secondary Care Andrea Porter
Art Director James Depree
Executive Director Edward Burkle